Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 22 of the 35 sources its claims cite were checked for support.

Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system

Open access
Zhang, Donglan S, Millet, Laure, Bellows, Brandon K, Lee, Sarah, Mann, Devin · 2026 · Journal of Telemedicine and Telecare

Abstract

ObjectivesRemote patient monitoring (RPM), combining home blood pressure measurements with telehealth services, effectively manages hypertension. Successful implementation of RPM programs at scale requires understanding program costs and financial sustainability. We evaluated the financial performance of an RPM program.MethodsConducted from March to June 2024 in the Cardiology Division at New York University Langone Health, the study used field observation, surveys, and micro-costing methods. A costing tool was developed to quantify program costs in 2024 US dollars, including personnel, equipment, and supplies. RPM-related services reimbursement rates were estimated using Medicare billing information. The return-on-investment (ROI) ratio was calculated by dividing net return (profit) by the RPM program costs. Sensitivity analyses assessed the impact of varying parameters on the ROI of RPM.ResultsThe average RPM program cost was estimated at $330 per patient (range: $208-$452). Major expenses included data review by staff ($172 per patient), blood pressure devices ($48 per patient), and phone communications ($36 per patient). ROI varied based on patient compliance with home blood pressure monitoring (≥16 days per month), with an average estimate of 22.2% (range: -11.1%-93.3%) per patient at a 55% compliance rate. The ROI was most sensitive to changes in data-review costs, insurance reimbursement rates, patient compliance, device setup, and communication costs.ConclusionsThe RPM program achieved a positive ROI from the perspective of a clinical division in a large healthcare system. Successful implementation and financial sustainability of RPM require efforts to reduce human resource costs and enhance patient engagement.

Overview

CoChat Summary

TL;DR

This economic evaluation of a remote patient monitoring for hypertension (RPM-HTN) program in the Cardiology Division at NYU Langone Health estimated an average program cost of $330 per patient and an average per-patient ROI of 22.2% at 55% compliance. It concludes the program achieved a positive short-term ROI from the clinical division perspective, with financial performance most sensitive to data-review costs, insurance reimbursement, and patient compliance.

Key findings

  • The average RPM-HTN program cost was $330 per patient (range: $208–$452), with projected total cost for 100 patients of $32,977 (range: $20,785–$45,168). Major costs were NP review of home BP data at $172 per patient (52.1% of expenses), Bluetooth-enabled BP devices at $48, and monthly phone communication at $36.
  • Average per-patient ROI was 22.2% (range: −11.1% to 93.3%) at a 55% compliance rate, meaning $1.22 returned per dollar invested. At the division level, base-case ROI was 19.5% (range: −12.8% to 89.5%), and estimated Medicare reimbursement per patient was $402.
  • Sensitivity analyses found the most influential factor was BP data-review cost ($86–$258; EV range −$13 to $159), followed by insurance reimbursement ($292–$525; EV range −$16 to $77), patient compliance (0.4–0.8; EV range $73–$128), device setup, and NP follow-up costs.
  • Other cost components included enrollment/consent/education at $29 per patient, annual Validic application depreciation at $23 per patient, staff training at $0.42 annually, and supplies at $1.70 per patient one time.

Methods

  • The study used activity-based micro-costing from March to June 2024 in the Cardiology Division at NYU Langone Health, combining field observation, staff surveys, and retrospective de-identified aggregated EHR data for 100 patients enrolled in RPM-HTN from January 1 to December 31, 2023. The sample had a median age of 66 years (range: 28–87), 30% male, and 52% covered by Medicare.
  • Costs were quantified in 2024 US dollars across personnel, program start-up, equipment, supplies, and miscellaneous categories. Revenue was estimated using the 2024 Medicare physician fee schedule for CPT codes 99453, 99454, 99457, and 99458, adjusted for New York with a rate of 1.061.
  • ROI was calculated as (total revenue − total cost) / total cost × 100%. Sensitivity analyses varied personnel time and hourly rates, patient compliance, insurance reimbursement rates, device setup, communication costs, and emergency-event probability.

Limitations

  • The paper states that ROI was estimated using Medicare reimbursement rates even though many patients have private insurance or Medicaid with varied policies; Medicare rates are state-specific; the analysis assessed only short-term ROI with an average enrollment duration of four months; no prospective cohort or implementation process measures were collected; only direct program costs and revenues were included, excluding system-level impacts; and estimates reflect one clinical division and the healthcare system perspective, limiting generalizability.
  • The paper also states that future studies should integrate patient and payer perspectives, assess patient-centered outcomes, and evaluate longer-term economic value.
  • Evident from the text: the analysis relies on a small retrospective sample of 100 patients in a single cardiology division, uses staff self-reports and aggregated de-identified data, and does not capture long-term health outcomes or broader societal costs and savings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/1357633x251403059

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 3 Not valid · 7 Not checked · 54 Own results and interpretations

41 more claims · 1 with their cited sources checked

Create a free account to see all 75 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Shepard DS, Hodgkin D, Anthony YE. Analysis of hospital costs: a manual for managers. World Health Organization, 2000.

Metadata

Authors
Zhang, D. S., Millet, L., Bellows, B. K., Lee, S., & Mann, D.
Affiliations
  • NYU Grossman Long Island School of Medicine (US)
  • New York University (US)
  • Columbia University Irving Medical Center (US)
  • NYU Langone Health (US)
Corresponding author
Zhang, Donglan S
Venue
Journal of Telemedicine and Telecare
Published
2026-01-19
Volume
32
Issue
8
Pages
669-678
ISSN
  • 1357-633X (ISSN-L)
  • 1758-1109
OpenAlex
W7124691873
Cited by
0
References
30
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Telemedicine and Telecare (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
  • National Institutes of Health (R01MD013886)
  • National Science Foundation (2129076)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
remote patient monitoring, antihypertensive therapy, return on investment, program costs, home blood pressure monitoring, telemedicine, financial sustainability, medication adherence, insurance reimbursement, micro-costing, cardiology
MeSH terms
Digital Health, Remote Patient Monitoring, Cost-Benefit Analysis, Humans, Hypertension, United States, Health Care Costs, Telemedicine, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system. https://app.cochat.ai/papers/10.1177/1357633x251403059
The paper
Zhang, D. S., Millet, L., Bellows, B. K., Lee, S., & Mann, D. (2026). Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system. Journal of Telemedicine and Telecare. https://doi.org/10.1177/1357633x251403059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.